檢索結果 - Graham P. Collins

Refine Results
  1. 1
    Subcutaneous vs intravenous rituximab in patients with non-Hodgkin lymphoma: a time and motion study in the United Kingdom

    Subcutaneous vs intravenous rituximab in patients with non-Hodgkin lymphoma: a time and motion study in the United Kingdom 由 Simon Rule, Graham P. Collins, Kunal Samanta

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    What do we know about duodenal‐type follicular lymphoma? From pathological definition to treatment options

    What do we know about duodenal‐type follicular lymphoma? From pathological definition to treatment options 由 Guilherme Duffles, Graham P. Collins, Vanderson Rocha

    出版 2019
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease

    Anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease 由 Toby A. Eyre, Dalia Khan, Georgina Hall, Graham P. Collins

    出版 2014
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Nodular lymphocyte-predominant Hodgkin lymphoma: advances in disease biology, risk stratification, and treatment

    Nodular lymphocyte-predominant Hodgkin lymphoma: advances in disease biology, risk stratification, and treatment 由 Ross Salvaris, Benjamin Allanson, Graham P. Collins, Chan Y. Cheah

    出版 2024
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Time now to<scp>TORC</scp>the<scp>TORC</scp>? New developments in m<scp>TOR</scp>pathway inhibition in lymphoid malignancies

    Time now to<scp>TORC</scp>the<scp>TORC</scp>? New developments in m<scp>TOR</scp>pathway inhibition in lymphoid malignancies 由 Toby A. Eyre, Graham P. Collins, Anthony H. Goldstone, Kate Cwynarski

    出版 2014
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era: a systematic review

    Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in... 由 Toby A. Eyre, Faouzi Djebbari, Amy A. Kirkwood, Graham P. Collins

    出版 2019
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  7. 7
    Care of haematology patients in a COVID‐19 epidemic

    Care of haematology patients in a COVID‐19 epidemic 由 John Willan, Andrew J. King, Sandy Hayes, Graham P. Collins, Andrew Peniket

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre

    Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre 由 Richard Haynes, Simon Read, Graham P. Collins, Sarah C. Darby, Christopher G. Winearls

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients with<i>de novo</i>diffuse large B cell lymphoma

    Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients with<i>de novo</i>di... 由 Toby A. Eyre, Richard Anthony Salisbury, David W. Eyre, Caroline Watson, Graham P. Collins, Chris S.R Hatton

    出版 2015
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  10. 10
    Assessing the impact of lockdown: Fresh challenges for the care of haematology patients in the COVID‐19 pandemic

    Assessing the impact of lockdown: Fresh challenges for the care of haematology patients in the COVID‐19 pandemic 由 John Willan, Andrew J. King, Faouzi Djebbari, Gareth D. H. Turner, Daniel Royston, Sue Pavord, Graham P. Collins, Andy Peniket

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy

    Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy 由 Toby A. Eyre, Harriet S. Walter, Sunil Iyengar, George Follows, Matt Cross, Christopher P. Fox, Andrew Hodson, Josh T. Coats, Santosh Narat, Nicholas Morley, Martin J.S. Dyer, Graham P. Collins

    出版 2018
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  12. 12
    Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma

    Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma 由 Sean H. Lim, Nicola Campbell, Marina Johnson, Débora Joseph‐Pietras, Graham P. Collins, Ann O’Callaghan, Christopher P. Fox, Matthew J. Ahearne, Peter Johnson, David Goldblatt, Andrew Davies

    出版 2021
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Guideline for the first‐line management of Classical Hodgkin Lymphoma — A British Society for Haematology guideline

    Guideline for the first‐line management of Classical Hodgkin Lymphoma — A British Society for Haematology guideline 由 George Follows, Sally F. Barrington, Kaljit Bhuller, Dominic Culligan, David J. Cutter, Eve Gallop‐Evans, Shireen Kassam, Wendy Osborne, Shalal Sadullah, William Townsend, Benjamin J. Uttenthal, Graham P. Collins

    出版 2022
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  14. 14
    Seronegative antibody‐mediated neurology after immune checkpoint inhibitors

    Seronegative antibody‐mediated neurology after immune checkpoint inhibitors 由 R. Wilson, David A. Menassa, Alexander J. Davies, Sophia Michael, Joanna Hester, Wilhelm Küker, Graham P. Collins, Judith Cossins, David Beeson, Neil Steven, Paul Maddison, Simon Rinaldi, Saiju Jacob, Sarosh R. Irani

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study

    Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study 由 Michael Wang, Radhakrishnan Ramchandren, Robert Chen, Lionel Karlin, Geoffrey Chong, Wojciech Jurczak, Ka Lung Wu, Mark Bishton, Graham P. Collins, Paul Eliadis, Fréderic Peyrade, Yihua Lee, Karl Eckert, Jutta K. Neuenburg, Constantine S. Tam

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Magrolimab Plus Rituximab in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: Phase 1/2 Trial 3-Year Follow-up

    Magrolimab Plus Rituximab in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: Phase 1/2 Trial 3-Year Follow-up 由 Amitkumar Mehta, Leslie Popplewell, Graham P. Collins, Sonali M. Smith, Ian W. Flinn, Nancy L. Bartlett, Nilanjan Ghosh, Gal Hacohen-Kleiman, Yanan Huo, Linda Su-Feher, Camille Renard, Ranjana H. Advani, Mark Roschewski

    出版 2024
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Identification of a Novel Mutation in MAGT1 and Progressive Multifocal Leucoencephalopathy in a 58-Year-Old Man with XMEN Disease

    Identification of a Novel Mutation in MAGT1 and Progressive Multifocal Leucoencephalopathy in a 58-Year-Old Man with XMEN Disease 由 Fatima Dhalla, Sarah Murray, Ross Sadler, Benjamin Chaigne-Delalande, Tomohiko Sadaoka, Elizabeth J. Soilleux, Gülbû Uzel, J. Philip Miller, Graham P. Collins, Christian S. R. Hatton, Malini Bhole, Berne Ferry, Helen Chapel, Jeffrey I. Cohen, Smita Y. Patel

    出版 2014
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  18. 18
    Initial Findings from a First-in-Human Phase 1a/b Trial of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients with Relapsed/Refractory B Cell Malignancies

    Initial Findings from a First-in-Human Phase 1a/b Trial of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients with Relapsed/Refractory B Cell Malignancies 由 Emma Searle, Francesco Forconi, Kim Linton, Alexey V. Danilov, Pam McKay, David John Lewis, Dima El‐Sharkawi, Mary Gleeson, John C. Riches, Sarah G. Injac, Ted Shih, Srinand Nandakumar, May Tan, Ganesh Cherala, Erin Meredith, Graham P. Collins

    出版 2023
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma

    Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma 由 Ariela Noy, Sven de Vos, Catherine Thiéblemont, Peter Martin, Christopher R. Flowers, Franck Morschhauser, Graham P. Collins, Shuo Ma, Morton Coleman, Shachar Peles, Stephen D. Smith, Jacqueline C. Barrientos, Alina Smith, Brian Munneke, Isaiah W. Dimery, Darrin M. Beaupre, Robert Chen

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety

    Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety 由 Wolfgang Hiddemann, Anna Maria Barbui, Miguel Canales, Paul Cannell, Graham P. Collins, Jan Dürig, Roswitha Forstpointner, Michael Herold, Mark Hertzberg, Magdalena Klánová, John Radford, John F. Seymour, Kensei Tobinai, Judith Trotman, Alis Burciu, Günter Fingerle‐Rowson, Marcel Wolbers, Tina Nielsen, Robert Marcus

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: